A new research by medical experts and researchers that a certain anti- cancer drug can help patients suffering from Dementia and Alzheimer's disease.
According to themarketbusiness.com, the drug RGFP966 can help Dementia and Alzheimer's disease patients by "rewiring the brain and keeping neurons alive."
New Rutgers research found that if this drug is administered to rats, the animal will be more attentive to their hearing, can remember and retain information, and most importantly develop new connections between brain cells.
When a person is suffering from Dementia or Alzheimer's disease, the memory- making ability of the brain is lost during the advanced stages of the disease. Research lead author Kasia M Bieszczad also said that "brain cells shrink and die because the synapses that transfer information from one neuron to another are no longer strong and stable. There is no therapeutic treatment available that reverses this situation." However, this drug can help in aiding this loss even during the disease's "worst case scenarios."
The research also says that this drug can make the brain cells more like plastics resulting to better connections that lead to enhancement of memory.
According to immortal.org, the drug RGFP966 is part of HDAC inhibitors drug class. These drugs are used in treating cancer as it "stop the activation of genes that turn normal cells in cancer cells."
The researchers are hopeful that this drug will serve as a breakthrough in helping patients to have their memory- making ability back.
During their experiments, scientists have used two groups of rats and both were exposed to a certain sound to receive reward. The group of rats who received the drug have better retention of the sounds for reward and reacted more correctly than the other group without the drugs. The experiment has shown that the drug can aid in improving one's memory.
The medical experts are now continuing their research and they are hopeful that this drug can create memories "closer to a snapshot of the actual experience instead of being sparse, limited or inaccurate."
What can you say about his new drug? Share it in the comments!
